Supernus seeks $100 million in public offering
Privately held Supernus Pharmaceuticals plans to raise $100 million in a public stock offering, according to the Rockville biotech's filing with the Securities and Exchange Commission.
Read more on
订阅:
博文评论 (Atom)
没有评论:
发表评论